190 related articles for article (PubMed ID: 17611627)
1. Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.
Lutz NW; Viola A; Malikova I; Confort-Gouny S; Audoin B; Ranjeva JP; Pelletier J; Cozzone PJ
PLoS One; 2007 Jul; 2(7):e595. PubMed ID: 17611627
[TBL] [Abstract][Full Text] [Related]
2. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis: The Role of Phase-Contrast MRI in the Differential Diagnosis of Active and Chronic Disease.
Öner S; Kahraman AS; Özcan C; Özdemir ZM; Ünlü S; Kamışlı Ö; Öner Z
Korean J Radiol; 2018; 19(1):72-78. PubMed ID: 29354002
[TBL] [Abstract][Full Text] [Related]
4. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
5. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
6. A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF.
Lutz NW; Viola A; Malikova I; Confort-Gouny S; Ranjeva JP; Pelletier J; Cozzone PJ
Biochem Biophys Res Commun; 2007 Mar; 354(1):160-4. PubMed ID: 17217913
[TBL] [Abstract][Full Text] [Related]
7. Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis-Metabolic Profile Analyses.
Podlecka-Piętowska A; Kacka A; Zakrzewska-Pniewska B; Nojszewska M; Zieminska E; Chalimoniuk M; Toczylowska B
J Mol Neurosci; 2019 Sep; 69(1):94-105. PubMed ID: 31134532
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy.
Nicoli F; Vion-Dury J; Confort-Gouny S; Maillet S; Gastaut JL; Cozzone PJ
C R Acad Sci III; 1996 Jul; 319(7):623-31. PubMed ID: 9011324
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
Mesaroc S; Drulović J; Lević Z; Perić V
Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.
Kapeller P; Ropele S; Enzinger C; Lahousen T; Strasser-Fuchs S; Schmidt R; Fazekas F
J Neurol; 2005 Oct; 252(10):1229-34. PubMed ID: 15895306
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.
Regenold WT; Phatak P; Makley MJ; Stone RD; Kling MA
J Neurol Sci; 2008 Dec; 275(1-2):106-12. PubMed ID: 18783801
[TBL] [Abstract][Full Text] [Related]
13. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Khalil M; Riedlbauer B; Langkammer C; Enzinger C; Ropele S; Stojakovic T; Scharnagl H; Culea V; Petzold A; Teunissen C; Archelos JJ; Fuchs S; Fazekas F
Mult Scler; 2014 Oct; 20(12):1569-77. PubMed ID: 24777275
[TBL] [Abstract][Full Text] [Related]
15. Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis.
Schirmer L; Rothhammer V; Hemmer B; Korn T
JAMA Neurol; 2013 Mar; 70(3):345-51. PubMed ID: 23599932
[TBL] [Abstract][Full Text] [Related]
16. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Villar LM; Espiño M; Costa-Frossard L; Muriel A; Jiménez J; Alvarez-Cermeño JC
Clin Chim Acta; 2012 Nov; 413(23-24):1813-6. PubMed ID: 22814197
[TBL] [Abstract][Full Text] [Related]
17. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis.
Dastidar P; Heinonen T; Lehtimäki T; Ukkonen M; Peltola J; Erilä T; Laasonen E; Elovaara I
J Neurol Sci; 1999 May; 165(1):36-42. PubMed ID: 10426145
[TBL] [Abstract][Full Text] [Related]
18. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases].
Pou Serradell A; Roquer González J; Perich Alsina X
Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729
[TBL] [Abstract][Full Text] [Related]
19. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
